Bae, Kim & Lee Recruits Global IP Dispute Experts Hong Junghoon and Kim Ilkwon

Enhancing Capabilities in IP and Healthcare Advisory

Hong Junghoon and Kim Ilkwon, attorneys at Bae, Kim & Lee LLC. Provided by Bae, Kim & Lee LLC

Bae, Kim & Lee LLC announced that it has recruited attorney Hong Junghoon, who has extensive experience in global patent and trade secret disputes, and attorney Kim Ilkwon, who specializes in the pharmaceutical and biotech sectors. Both attorneys will join Bae, Kim & Lee’s Intellectual Property (IP) Group and the Technology Disputes and Investigation Response Center, strengthening the firm’s capabilities in IP advisory and dispute response.

Attorney Hong Junghoon majored in electrical engineering and statistics at Seoul National University and studied applied mathematics at Harvard University in the United States. He graduated from the law school at Seoul National University and passed the bar exam. At Lee & Ko, he handled numerous global patent and trade secret disputes, including lawsuits in U.S. federal courts and before the International Trade Commission (ITC). Leveraging his technological understanding and statistical analysis skills, he developed expertise in the electronics, pharmaceutical, and biotech fields. He led a settlement in simultaneous lawsuits across nine countries concerning patent disputes over HIV treatments between multinational pharmaceutical companies, and secured a non-prosecution decision in cases related to botulinum strain disputes.

Attorney Kim Ilkwon majored in life sciences at Seoul National University, completed an integrated master’s and doctoral program at the same university, and graduated from Korea University Law School. He has provided litigation and advisory services in the pharmaceutical, biotech, and healthcare sectors, achieving significant results in blockbuster drug patent disputes and biosimilar-related cases. Notably, he worked with attorney Hong Junghoon on HIV treatment patent disputes.

Nam Moonki, head of the IP Group, stated, “With the addition of these two attorneys, who possess both technological understanding and data analysis capabilities, our IP Group’s expertise has been further enhanced. We will now be able to respond with greater precision to complex, high-level IP and healthcare cases involving multifaceted issues.”

This content was produced with the assistance of AI translation services.